Wang Ruihua, Yang Xiuchun, Zhu Wenyu, Liang Wei, Li Zhenglong, Chen Cheng
Department of Thoracic Surgery, Liupanshui People's Hospital, Liupanshui, China.
Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Gland Surg. 2022 May;11(5):938-942. doi: 10.21037/gs-22-218.
Thymoma is the most common tumor of the anterior mediastinum, especially in adults, and accounts for 20-25% of all mediastinal tumors and 50% of anterior mediastinal tumors. Thymomas originating from thymus epithelial cells or lymphocytes are the most common, and account for 95% of thymomas. Thymoma is a relatively rare and inert disease of the chest, and many thymoma patients have a long survival period despite disease progression. Surgery is the first choice of treatment for thymoma, but controversy remains as to the best approach for treating giant thymoma. The incidence of large tumors in the thorax is low, surgical treatment is difficult, and surgical risk is high. A thymoma with myasthenia gravis is common, but a huge thymoma with pure red cell aplasia is rare.
Our hospital (Liupanshui People's Hospital) admitted a patient with a large thymoma. The 37-year-old female patient had chest pain without obvious cause, accompanied by chest tightness and shortness of breath for 3 days. The patient appeared to have severe anemia. The patient's initial hemoglobin level was 51 g/L. A computed tomography (CT) scan after hospitalization revealed a large soft tissue mass in the left thoracic cavity, about 22.0 cm × 18.0 cm × 15.0 cm in size, of mixed density, with an intact boundary envelope, partial pulmonary atelectasis of the left lung, and pleural fluid on the left. The tumor was successfully removed by left anterolateral incision, and postoperatively, the patient s compression and anemia improved significantly, and a pathologic diagnosis of type A thymoma.
Through a literature review and case analysis, we extend understandings of thymoma. Clinical differential diagnosis should be made before surgery, which is very important for making treatment plan. Our results can provide a reference for the clinical treatment of thymoma, and strive to provide the best treatment for patients.
胸腺瘤是前纵隔最常见的肿瘤,尤其在成人中,占所有纵隔肿瘤的20% - 25%以及前纵隔肿瘤的50%。起源于胸腺上皮细胞或淋巴细胞的胸腺瘤最为常见,占胸腺瘤的95%。胸腺瘤是一种相对罕见且进展缓慢的胸部疾病,许多胸腺瘤患者尽管疾病进展但生存期较长。手术是胸腺瘤的首选治疗方法,但对于巨大胸腺瘤的最佳治疗方法仍存在争议。胸部大肿瘤的发病率低,手术治疗困难,手术风险高。合并重症肌无力的胸腺瘤很常见,但合并纯红细胞再生障碍性贫血的巨大胸腺瘤则很罕见。
我院(六盘水市人民医院)收治了一名巨大胸腺瘤患者。该37岁女性患者无明显诱因出现胸痛,伴有胸闷、气短3天。患者出现严重贫血。患者初始血红蛋白水平为51g/L。住院后计算机断层扫描(CT)显示左胸腔有一个巨大软组织肿块,大小约为22.0 cm×18.0 cm×15.0 cm,密度不均,边界包膜完整,左肺部分肺不张,左侧胸腔有胸腔积液。通过左前外侧切口成功切除肿瘤,术后患者的压迫症状和贫血明显改善,病理诊断为A型胸腺瘤。
通过文献复习和病例分析,我们对胸腺瘤有了进一步的认识。术前应进行临床鉴别诊断,这对制定治疗方案非常重要。我们的结果可为胸腺瘤的临床治疗提供参考,努力为患者提供最佳治疗。